期刊文献+

志贺菌rfbA基因突变体的构建

原文传递
导出
摘要 目的构建弗氏2a志贺菌301 rfbA基因缺失突变株,初步探究志贺菌脂多糖合成与糖蛋白合成通路是否相关。方法首先用PCR扩增出rfbA基因上下游同源臂,构建含有kan基因的打靶片段,采用λ-Red重组系统对rfbA基因进行缺失,用PCR进行初步验证,然后通过LPS的银染方法进行进一步验证。随后,制备野生株、rfbA缺失突变株的全菌蛋白样品,进行双向电泳后比较野生株301和rfbA缺失株的蛋白表达谱。结果成功构建了301 rfbA缺失突变株。在LPS的银染实验中,rfbA突变株在凝胶中未形成一长串的梯状条带。在双向电泳实验中,野生株和突变株没有明显的蛋白差异点。结论获得了301 rfbA基因缺失突变体,初步认为志贺菌中不存在与脂多糖O-抗原合成相关的蛋白糖基化途径。
出处 《军事医学》 CAS CSCD 北大核心 2012年第5期399-400,F0003,共3页 Military Medical Sciences
基金 国家自然科学基金资助项目(81071324,81171531) 国家973计划资助项目(2011CB504901)
  • 相关文献

参考文献22

  • 1朱力,王恒樑.志贺氏菌Ⅲ型分泌系统及其致病机理[J].微生物学报,2010,50(11):1446-1451. 被引量:4
  • 2Kotloff KL,Winickoff JP,Ivanoff B. Global burden of Shigella infections:implications for vaccine development and implementation of control strategies[J].Bulletin of the World Health Organization,1999,(08):651-666.
  • 3Mescher MF,Strominger JL,Watson SW. Protein and carbohydrate composition of the cell envelope of Halobacterium salinarum[J].Bacteriology,1974,(02):945-954.
  • 4Hitchen PG,Dell A. Bacterial glycoproteomics[J].Microbiology,2006,(06):1575-1580.
  • 5Yurist-Doutsch S,Chaban B,VanDyke DJ. Sweet to the extrem:protein glycosylation in Archaea[J].Molecular Microbiology,2008,(05):1079-1084.
  • 6Abu-Qarn M,Eichler J,Sharon N. Not just for eukarya anymore:protein glycosylation in Bacteria and Archaea[J].Current Opinion in Structural Biology,2008,(05):544-550.
  • 7Schaffer C,Messner P. Surface-layer glycoproteins:an example for the diversity of bacterial glycosylation with promising impacts on nanobiotechnology[J].Glycobiology,2004,(08):31R-41R.
  • 8Szymanki CM,Michael F St,Jarrell HC. Detection of conserved N-linked glycans and phase variable lipooligosaccharides and capsules from Campylobacter cells by mass spectrometry and high resolution magicangle spinning NMR spectroscopy detection[J].Biological Chemistry,2003,(27):24509-24520.
  • 9Wacker M,Linton D,Hitchen PG. N-linked glycosylation in Campylobacter jejuni and its functional transfer into E.coli[J].Science,2002,(5599):1790-1793.doi:10.1126/science.298.5599.1790.
  • 10Szymanski CM,Yao R,Ewing CP. Evidence for a system of general protein glycosylation in Campylobacter jejuni[J].Molecular Microbiology,1999,(05):1022-1030.doi:10.1046/j.1365-2958.1999.01415.x.

二级参考文献28

  • 1Pendaries C, Tronchere H, Arbibe L, Mounier J, Gozani O, Cantley L, Fry MJ, Gaits-lacovoni F, Sansonetti PJ, Payrastre B. PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection. The EMBO journal, 2006, 25 (5) : 1024- 1034.
  • 2Clark CS, Maurelli AT. Shigella flexneri inhibits staurosporine-induced apoptosis in epithelial cells. Infection and immunity, 2007, 75 (5) : 2531-2539.
  • 3Faherty CS, Maurelli AT. Spa15 of Shigella flexneri is secreted through the type III secretion system and prevents staurosporine-induced apoptosis. Infection and immunity, 2009, 77( 12): 5281-5290.
  • 4Kim M, Ogawa M, Fujita Y, Yoshikawa Y, Nagai T, Koyama T, Nagai S, Lange A, Fassler R, Sasakawa C. Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment. Nature, 2009, 459 ( 7246 ) : 578-582.
  • 5Mandic-Mulec I, Weiss J, Zychlinsky A. Shigella flexneri is trapped in polymorphonuclear leukocyte vacuoles and efficiently killed. Infection and immunity, 1997, 65(1) : 110-115.
  • 6Rohde JR, Breitkreutz A, Chenal A, Sansonetti PJ,Parsot C. Type III secretion effectors of the IpaH family are E3 ubiquitin ligascs. Cell host & microbe, 2007, 1 (1): 77-83.
  • 7Kim DW, Lenzen G, Page AL, Legrain P, Sansonetti PJ, Parsot C. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proceedings of the National Academy of Sciences of the United States of America, 2005, 102 ( 39 ) : 14046-14051.
  • 8Li H, Xu H, Zhou Y, Zhang J, Long C, Li S, Chert S, Zhou JM, Shao F. The phosphothreonine lyase activity of a bacterial type III effector family. Science, 2007, 315 (5814) : 1000-1003.
  • 9Zurawski DV, Mumy KL, Faherty CS, McCormick BA, Maurelli AT. Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein. Molecular microbiology, 2009, 71 (2) : 350-368.
  • 10Newton H J, Pearson JS, Badea L, Kelly M, Lucas M, Holloway G, Wagstaff KM, Dunstone MA, Sloan J, Whisstock JC, Kaper JB, Robins-Browne RM, Jans DA, Frankel G, Phillips AD, Coulson BS, Hartland EL. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS pathogens, 2010, 6(5) : e1000898.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部